Streptococcus pyogenes

 Streptococcus pyogenes is a species of Gram-positive bacteria that belongs to the Streptococcus genus. This pathogenic bacterium is known to cause several human diseases, ranging from minor skin infections to life-threatening systemic disorders.

Streptococcus Pyogenes (Group A Strep) (52602892639)

Characteristics

Streptococcus pyogenes is a spherical bacterium (coccus) that usually forms chains. It is classified as a Group A Streptococcus (GAS) due to its cell wall carbohydrate antigen.

Pathogenesis and Immunity

The ability of S. pyogenes to cause disease is due to various virulence factors. These include M proteins that prevent phagocytosis, enzymes such as streptokinase and hyaluronidase that promote tissue invasion, and toxins including streptolysins and pyrogenic exotoxins. The human immune response includes the production of antibodies against these factors, particularly M proteins.

Streptococcus Pyogenes (Group A Strep) (52602981880)

Clinical Manifestations

• S. pyogenes can cause a variety of diseases:
• Pharyngitis: Also known as strep throat, this is the most common illness caused by S. pyogenes. Symptoms include sore throat, fever, and swollen lymph nodes.
• Skin Infections: These include impetigo, a superficial skin infection causing sores and blisters, and cellulitis, a deeper skin and tissue infection.
• Invasive Infections: More serious, these can include necrotizing fasciitis (a severe soft tissue infection), streptococcal toxic shock syndrome (a severe systemic response), and bacteremia (bacteria in the blood).
• Post-Infectious Sequelae: Certain strains can trigger autoimmune reactions leading to rheumatic fever, which can damage the heart, and glomerulonephritis, which can damage the kidneys.

Diagnosis

Diagnosis usually involves microbiological culture of a throat swab or other specimen, although rapid antigen detection tests can be used for initial screening. Confirmation is typically done by identification of the bacterium based on its characteristic beta-hemolysis on blood agar and Group A carbohydrate antigen.

Treatment

Treatment is typically with antibiotics, most commonly penicillin, to which the bacterium is usually sensitive. Early treatment can prevent the autoimmune complications of rheumatic fever and glomerulonephritis.

References

<references>

• Bisno AL, Stevens DL. (1996). Streptococcal infections of skin and soft tissues. New England Journal of Medicine, 334(4), 240–245.
• Cunningham MW. (2000). Pathogenesis of group A streptococcal infections. Clinical Microbiology Reviews, 13(3), 470–511.
• Carapetis JR, Steer AC, Mulholland EK, Weber M. (2005). The global burden of group A streptococcal diseases. Lancet Infectious Diseases, 5(11), 685–694.

</references>

This article is a medical stub. You can help WikiMD by expanding it!
Most recent articles Ongoing trials	Wikipedia